I'm not sure which drug you mean. MATHS is meant to be an in-hospital protocol using cheap, available, and approved drugs. EVMS has different protocols for prophylaxis and home care.
The "dire straights" concept of the FDA approving drugs for patients who are dying has actually killed a lot of Covid-19 patients: Especially for antivirals, that might stop viral replication very early but have no effect (and possibly do harm) to patients in the later autoimmune phase of the disease.
I saw a video in which a doctor admitted they were only giving remdesivir to those dying patients because they had a very limited supply. So they reserve the antiviral drug for patients who may not even have much virus any more and instead are dying from their own immune system's cytokine storm! Sounds like a waste of time and scarce drug to me.
